Eltrombopag Tablet (Orken) Manufacturers India & Exporters
Taj Pharmaceuticals – The Trusted Eltrombopag 25mg Tablet (Orken) Manufacturer & Supplier in India
Taj Pharmaceuticals, headquartered in Vapi, Gujarat, stands as a renowned manufacturer, exporter, and supplier of Eltrombopag 25mg Tablets, marketed under the name Orken. With a steadfast commitment to pharmaceutical excellence and global regulatory compliance, we provide high-quality Eltrombopag Tablets to domestic markets and international clients across Africa, the Middle East, and LATAM regions. Our state-of-the-art WHO-GMP-certified facilities and unwavering dedication to therapeutic precision have made us a top choice for healthcare institutions, PCD franchise partners, and pharmaceutical distributors worldwide.
What is Eltrombopag 25mg Tablet (Orken)?
Eltrombopag is an oral thrombopoietin receptor agonist (TPO-RA) used to stimulate the production of platelets in the bone marrow. It is primarily indicated for:
- Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) in adults and children who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
- Thrombocytopenia associated with chronic Hepatitis C virus (HCV) infection to allow for interferon-based therapy.
- Severe Aplastic Anemia (SAA) in patients who are refractory to immunosuppressive therapy.
Taj Pharma – Leading Manufacturer of Eltrombopag 25mg Tablets in India
With more than two decades of experience in formulation development and international export, Taj Pharma has become a pillar in India’s pharmaceutical manufacturing sector. Our Eltrombopag 25mg Tablets (Orken) are developed under the most stringent quality protocols, ensuring:
- Purity
- Stability
- Optimal bioavailability
- Compliance with international pharmacopoeias
We follow ICH guidelines, and our manufacturing units are certified by WHO-GMP, EU-GMP, and other leading regulatory agencies. This ensures that every batch of Eltrombopag 25mg Tablet meets the highest international standards for efficacy and safety.
Mechanism of Action: How Eltrombopag Works
Eltrombopag is a non-peptide agonist that binds to the transmembrane domain of the thrombopoietin receptor (TPO-R or c-Mpl). This stimulates megakaryocyte proliferation and differentiation, leading to an increase in platelet counts in patients with chronic thrombocytopenia. The response time typically ranges from 7 to 14 days, depending on the patient’s condition and treatment adherence.
Therapeutic Indications of Eltrombopag Tablets
Our Eltrombopag 25mg Tablets are prescribed for:
- Chronic ITP (Idiopathic Thrombocytopenic Purpura)
For adults and children aged 1 year and older with ITP lasting more than 6 months and an insufficient response to prior treatment. - Chronic Hepatitis C-associated Thrombocytopenia
To enable initiation and maintenance of interferon-based therapy. - Severe Aplastic Anemia
In patients unresponsive to immunosuppressive therapy or requiring long-term platelet transfusions.
Benefits of Choosing Taj Pharmaceuticals for Eltrombopag 25mg Tablet
- PAN India Supply Chain
We distribute across all major cities including Mumbai, Delhi, Chennai, Kolkata, Hyderabad, Ahmedabad, and Bangalore. - PCD Pharma Franchise Opportunities
We offer monopoly-based PCD franchise partnerships for Eltrombopag Tablets across India with comprehensive marketing support. - Affordable & Competitive Pricing
With our vertically integrated production model, we provide Eltrombopag Tablets at the most competitive prices in India without compromising quality. - Regulatory Support for Export
We support global partners with complete documentation, including CTD Dossiers, COAs, MSDS, and COPPs, aiding smooth product registration in export markets.
Dosage & Administration Guidelines
- Dosage for Adults with ITP: Typically starts at 50 mg once daily; however, some patients begin with 25 mg/day, depending on ethnicity and liver function.
- Pediatric Use: 25 mg once daily for children aged 1 to 5 years and 50 mg once daily for ages 6 to 17 years.
- Severe Aplastic Anemia: Often initiated under specialist supervision and adjusted based on response.
Administration Tip: Eltrombopag must be taken on an empty stomach, 1 hour before or 2 hours after meals to optimize absorption. Avoid dairy and calcium-rich products within 4 hours of dosing.
Precautions and Safety Considerations
- Monitor liver function tests regularly.
- Do not use in patients with hepatic decompensation or severe liver disease without specialist advice.
- Risk of thrombosis if platelet count exceeds 400,000/mm³.
- Avoid concomitant use with aluminum, calcium, iron, magnesium, selenium, or zinc supplements.
Storage and Stability
- Store below 30°C, away from direct sunlight and moisture.
- Keep in original blister packaging until use.
- Shelf life: 24 to 36 months, depending on regulatory specifications per market.
Export Markets and Global Reach
Taj Pharmaceuticals proudly exports Eltrombopag Tablets to over 28 countries, including:
- Africa: Nigeria, Kenya, Ghana, Ethiopia, Tanzania
- Middle East: UAE, Saudi Arabia, Iraq, Jordan
- LATAM: Peru, Colombia, Bolivia, Guatemala
- CIS & SEA: Kazakhstan, Uzbekistan, Myanmar, Vietnam
We offer private label manufacturing, bulk exports, and institutional supply to government tenders, hospitals, NGOs, and UN agencies.
Why Choose Taj Pharma for Eltrombopag Tablet (Orken)?
✅ Trusted Brand across regulatory bodies and multinational clients
✅ Advanced R&D and Stability Studies for long-term efficacy
✅ End-to-End Support from formulation to shipment
✅ 24/7 Customer Support and Technical Assistance
✅ Ethical Manufacturing with Environment Compliance
PCD Pharma Franchise for Eltrombopag Tablet
We invite pharma distributors, startups, and entrepreneurs to collaborate under our PCD Pharma Franchise model. Get access to:
- Monopoly marketing rights
- Promotional material kits
- Training and medical literature
- Consistent product supply
- High-margin opportunities
Partner with Taj Pharma to grow your business with Eltrombopag 25mg Tablet and over 500+ therapeutic lines.
Technical Specifications of Eltrombopag Tablet
- Product Name: Eltrombopag 25mg Tablet
- Brand Name: Orken (Export/Private Label Available)
- Strength: 25mg
- Dosage Form: Oral Tablet
- Route of Administration: Oral
- Packaging: Blister Pack of 7, 14, or 28 Tablets
- Therapeutic Category: Platelet Enhancer
- Regulatory Documentation: Available (CTD/ACTD/COA/MSDS)
- Shelf Life: 2-3 Years
- Storage: Below 30°C in dry conditions
Contact Taj Pharmaceuticals Today
For Distributors, Hospitals, Government Procurement & PCD Franchise Partnerships:
📧 Email: info@tajpharma.com
📞 WhatsApp/Call: +91 84484 44095
🌐 Visit: www.tajpharma.com
📍 Office: Vapi, Gujarat – India | Branches in Mumbai, Delhi, Dubai
Boost your portfolio with high-quality Eltrombopag 25mg Tablets from India’s trusted pharmaceutical manufacturer – Taj Pharma.
